A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis

Neonatology

Volumn 105, Issue 4, 2014, Pages 290-296

  Lam, Hugh S ^a   Tam, Yuk H ^b   Poon, Terence C W ^a   Cheung, Hon M ^a   Yu, Xinting ^a   Chan, Brenda P L ^a   Lee, Kim H ^b   Lee, Benjamin S C ^a   Ng, Pak C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Fish oil based lipid preparation; Newborn infants; Parenteral nutrition associated cholestasis; Randomised controlled trial

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN GLUCURONIDE; FISH OIL; SOYBEAN OIL; BILIRUBIN; BIOLOGICAL MARKER; EMULSION; LIPID EMULSION; OMEGAVEN; PHOSPHOLIPID; SOYBEAN OIL, PHOSPHOLIPID EMULSION; INTRALIPID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD GROWTH; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; FAT INTAKE; FEMALE; HUMAN; INFANT; LIPID BLOOD LEVEL; LIVER FUNCTION; LIVER FUNCTION TEST; MALE; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; TREATMENT DURATION; ADMINISTRATION AND DOSAGE; BIRTH WEIGHT; BLOOD; CHILD DEVELOPMENT; COMPARATIVE STUDY; EARLY TERMINATION OF CLINICAL TRIAL; EMULSION; GESTATIONAL AGE; GROWTH, DEVELOPMENT AND AGING; HEAD; HONG KONG; INFANT NUTRITION; LIVER; LOW BIRTH WEIGHT; METABOLISM; NEWBORN; NUTRITIONAL STATUS; PREMATURITY; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; WEIGHT GAIN; ANTHROPOMETRIC PARAMETERS; APGAR SCORE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GROWTH RATE; MAJOR CLINICAL STUDY;

ALANINE TRANSAMINASE; BILIRUBIN; BIOLOGICAL MARKERS; BIRTH WEIGHT; CHILD DEVELOPMENT; CHOLESTASIS; DOUBLE-BLIND METHOD; EARLY TERMINATION OF CLINICAL TRIALS; EMULSIONS; ENTERAL NUTRITION; FAT EMULSIONS, INTRAVENOUS; FEMALE; FISH OILS; GESTATIONAL AGE; HEAD; HONG KONG; HUMANS; INFANT; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; LIVER; MALE; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; SOYBEAN OIL; TIME FACTORS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 84895562922     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000358267     Document Type: Article

References (14)

1. Wessel JJ, Kocoshis SA: Nutritional management of infants with short bowel syndrome. Semin Perinatol 2007; 31: 104-111.
2. Ng PC, Lee CH, Wong SP, Lam HS, Liu FY, So KW, et al: High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants. Gastroenterology 2007; 132: 1726-1739.
3. Wales PW, de SN, Kim JH, Lecce L, Sandhu A, Moore AM: Neonatal short bowel syndrome: a cohort study. J Pediatr Surg 2005; 40: 755-762.
4. Clayton PT, Whitfield P, Iyer K: The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998; 14: 158-164.
5. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C: Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2000; 24: 345-350.
6. Cheung HM, Lam HS, Tam YH, Lee KH, Ng PC: Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fishoil-based lipid. Clin Nutr 2009; 28: 209-212.
7. Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, et al: Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006; 118:e197-e201.
8. Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, et al: Safety and efficacy of a fish-oilbased fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008; 121:e678-e686.
9. Puder M, Valim C, Meisel JA, Le HD, de Meijer VE, Robinson EM, et al: Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009; 250: 395-402.
10. Soden JS, Lovell MA, Brown K, Partrick DA, Sokol RJ: Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure. J Pediatr 2010; 156: 327-331.
11. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW: Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009; 48: 209-215.
12. de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M: Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease. Pediatr Surg Int 2009; 25: 123-124.
13. Vieira de BK, Gomes de AG, Xavier RA, Real Martinez CA, Ribeiro ML, Gambero A, et al: Effects of a high fat or a balanced omega-3/omega-6 diet on cytokines levels and DNA damage in experimental colitis. Nutrition 2011; 27: 221-226.
14. Cowles RA, Ventura KA, Martinez M, Lobritto SJ, Harren PA, Brodlie S, et al: Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. J Pediatr Surg 2010; 45: 84-87.